Trial Details

Recruiting
Basic Information
Clinical ID c3010
Identifier NCT02453607
Trial Title The Impact of 6MP Metabolite Levels on Infliximab Pharmacokinetics and Anti-infliximab Antibodies in Crohn's Disease
Trial URL Visit Original Page
Study Information
Study Results

No results available
Conditions Inflammatory Bowel Disease;Crohn's Disease;Inflammatory Bowel Disease;Crohn's Disease;Inflammatory Bowel Disease;Crohn's Disease;Inflammatory Bowel Disease;Crohn's Disease
Interventions Drug: Infliximab;Drug: thiopurine;Drug: Infliximab;Drug: thiopurine;Drug: Infliximab;Drug: thiopurine;Drug: Infliximab;Drug: thiopurine
Participant Information
Sponsor Ernest Seidman
City -
Country/Region Canada
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type Observational
Phase Not Available
Time Information
Start Date 2025-04-24
Primary Completion Date -
Completion Date -